Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label gastrointestinal adverse events. Show all posts
Showing posts with label gastrointestinal adverse events. Show all posts
Monday, July 26, 2010

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events..

›
Tapentadol (see structure) is a new molecular entity that is structurally similar to tramadol (Ultram). It is a centrally-acting an...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.